The UroLift® System can get men off BPH medications and avoid major surgery.
Now, there’s good news. The UroLift® System – the minimally invasive, breakthrough treatment option – is available near you.
The UroLift System uses a revolutionary approach to treating BPH that lifts and holds the enlarged prostate tissue so it no longer blocks the urethra.
The UroLift System is the only BPH treatment shown not to cause new and lasting sexual dysfunction,* while providing rapid relief and recovery of BPH symptoms.3-9 It is the only available BPH treatment performed by a urologist that does not require heating, cutting, or removal of the prostate tissue.
The UroLift System treatment has demonstrated a significant improvement in quality of life for patients compared to medications.6 Symptom relief is better than reported for medications, with a risk profile better than surgical procedures.3,4
Typically, there is no overnight stay or catheter required after treatment with the UroLift System.3 The most common adverse events reported include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
The International Prostate Symptom Score (IPSS) is a scoring system used to screen for and diagnose benign prostatic hyperplasia (BPH). The survey asks seven urinary symptom questions and one quality of life question to help determine the severity of your BPH. Understanding your specific situation will better equip you to choose the right treatment for your BPH so that you can get back to enjoying life.
BPH causes bothersome urinary symptoms that can interrupt your quality of life and the activities you enjoy. As an enlarged prostate presses on and blocks the urethra, symptoms like urgent need to urinate, difficulty starting or straining during urination, incomplete emptying, or even painful urination can occur. If you are diagnosed with BPH, learn how the UroLift System may be the right treatment option for you.
Many men living with enlarged prostate (BPH) symptoms take prescription medications after they’re diagnosed, although these often don’t provide adequate relief and may cause dizziness, fatigue, and sexual dysfunction.4 Medications may not need to be a lifelong burden, however, and men don’t need to wait until surgery is required to address the problem. In fact, they can avoid traditional surgery altogether.
The first step is to make an appointment with your urologist to determine if you are an appropriate candidate for the treatment. Your physician’s office staff can work with you and your health plan to learn more about your healthcare benefits specific to the UroLift System treatment.
Yes, all Medicare carriers provide benefits for the UroLift System treatment when medically necessary. Discuss the UroLift System treatment with your physician to determine if it is the right option for you.
Center of Excellence: Designation is provided to individual physicians who have achieved a higher level of training and experience with the UroLift® System. Learn More
This practice offers the UroLift System procedure in their office.
Note: Names and details are provided for your information only. Decisions regarding choice of physician and treatment are a patient's responsibility, as is all communication and interaction with listed medical professionals. Any information you send to a physician is not covered by the Teleflex Incorporated (Teleflex) Privacy Policy: https://www.teleflex.com/usa/en/legal/internet-privacy-policy/index.html.
The list of physicians generated by your search criteria is based on the ZIP code or city that you entered. You will have the option to sort search results by proximity to the ZIP code or city that you entered or by listing UroLift® Center of Excellence (COE) physicians at the top. UroLift® COE physicians have fulfilled the designation requirements for the UroLift® COE Program.
The information and content in the Physician Locator are provided solely by the physicians. This list was created to support patients who want to learn more about the UroLift® System by helping connect them to physicians who currently have demonstrated qualifications and interest in providing quality care with the UroLift® System. All physicians have been given the choice to enable a link to their email address within the listing associated with their name.
Physicians listed on the Physician Locator pay no fee for inclusion. Some physicians on this list may purchase products from, provide consulting services to and/or be a party to a co-marketing agreement with Teleflex. Teleflex makes no representations or warranties regarding, and shall not be responsible for, the competencies or skill level of any of the physicians listed on the Physician Locator or the quality of their procedural outcomes. You and your physician must determine if the UroLift® System treatment is the right procedure for you.
NeoTract | Teleflex reserves the right to remove and/or exclude any physician from the Physician Locator immediately and without notice in its sole discretion in the event that NeoTract |Teleflex becomes aware of (i) any alleged or suspected fraud or abuse or violation of law, arising out of any activity involving the physician, (ii) any alleged or suspected violations of any federal or state health care program requirements by the physician, (iii) any threatened, proposed, or actual revocation of license/certification, suspension, exclusion, or debarment of the physician, and/or (iv) any subpoena, legal process, civil investigative demand, discovery request, or similar request for information involving the physician.
The current requirements to be listed on the Physician Locator consist of:
Physicians currently listed on the Physician Locator who were trained prior to creation of the UroLift® Proficiency Pathway received equivalent surgeon training to the requirements outlined above, including instructional didactic sessions, clinical video review and hands-on UroLift® System use. The current and prior training programs focus on identifying appropriate patient candidates; preparation and operation of the UroLift® System; and surgical technique.
To remain on the Physician Locator, a physician must:
The case completion criterion is assessed every six calendar months, with the review periods occurring January 1– June 30 and July 1 – December 31. The education module completion criterion is assessed at the end of the calendar year. A physician will be removed from the Physician Locator if they have not met the above requirements. A physician will be added back to the Physician Locator once they have completed at least 5 cases within the last review period and have completed an education module during the calendar year.
The UroLift® Center of Excellence (COE) Program is designed to enhance patient outcomes and experience. Urologists included in the UroLift® COE Program have achieved a higher level of training with the UroLift® System and demonstrated a commitment to care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH) or an enlarged prostate.
Our UroLift® COE designation criteria changed effective January 15, 2021. All those achieving UroLift® COE designation on or after January 15, 2021 are required to meet the following criteria.
Those achieving UroLift® COE designation prior to January 15, 2021 were required to meet the following criteria:
*Please note, in situations where elective procedures were not allowed due to COVID-19, those months will not be included in the 12-month period for designation or re-designation. Therefore, the assessment period may not be consecutive months.
**Excluding cases completed during UroLift® Proficiency Pathway training
{{notes}}
{{/if}}{{street_address}}
{{#if street_address_2}}{{street_address_2}}
{{/if}}
{{city}}, {{state}} {{zip}}
{{phone}}
{{/if}} {{#if website}}{{/if}} {{#if distance}}{{notes}}
{{/if}}{{street_address}}
{{#if street_address_2}}{{street_address_2}}
{{/if}}
{{city}}, {{state}} {{zip}}
{{phone}}
{{/if}} {{#if website}}{{/if}} {{#if distance}}Source Information
1. NeoTract US Market Model estimates for 2018
2. Berry, et al., J Urol 1984
3. Roehrborn, J Urology 2013
4. AUA BPH Guidelines 2003, 2010, 2018
5. Shore Can J Urol 2014
6. Roehrborn et al. Can J Urol 2017
7. Naspro, Eur Urol 2009
8. Montorsi, J Urol 2008
9. McVary, J Sex Med 2016
*No instances of new, sustained erectile or ejaculatory dysfunction
Indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge (Roehrborn, J Urology 2013). Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Speak with your doctor to determine if you may be a candidate.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
Teleflex, the Teleflex logo, and UroLift are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Barrigel is a registered trademark of Galderma Holdings S.A. Rx only.
© 2025 Teleflex Incorporated. All rights reserved. Terms of Use Privacy Policy Patient Safety